| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86626 |
DOTA-CH2-Ph-azide(HCl salt),DOTA螯合剂 |
183 |
h |
2024-12-13 |
| 86627 |
Glcβ1-4Glc-O-(CH2)3-NH-DBCO ， 含DBCO的纤维二糖(接头-DBCO A) |
201 |
kx |
2024-12-13 |
| 86628 |
DOTA-DBCO双功能螯合剂 |
174 |
h |
2024-12-13 |
| 86629 |
Glcβ1-4Glcβ1-4Glc-O-(CH2)3-NH-DBCO ， 含DBCO的纤维三糖(接头-DBCO A) |
178 |
kx |
2024-12-13 |
| 86630 |
DOTA-(COOt-Bu)3-NHS,CAS:819869-77-7 |
147 |
h |
2024-12-13 |
| 86631 |
GlcNAcβ1-3Gal与生物素和硬脂酸链相连(接头-BT-STEA A) |
215 |
kx |
2024-12-13 |
| 86632 |
棕榈酸-酮缩硫醇-羧酸，C16-TK-COOH |
199 |
wyh |
2024-12-13 |
| 86633 |
DOTA-(COOt-Bu)3-C2-NH2,CAS:173308-19-5 |
174 |
h |
2024-12-13 |
| 86634 |
Methyltetrazine-PEG5-CO-piperazine-C3-Mal的应用领域 |
198 |
kx |
2024-12-13 |
| 86635 |
DO-(CH2COOt-Bu)2,环状多胺多羧类配体,CAS：162148-48-3 |
181 |
h |
2024-12-13 |
| 86636 |
4,7,10-TRI-(T-BUTYLOXYCARBONYLMETHYL) |
121 |
h |
2024-12-13 |
| 86637 |
carboxymethyl-dextran-A2-gadolinium-DOTA |
145 |
h |
2024-12-13 |
| 86638 |
Tat-DOTA,DOTA-TAT(48-60),DOTA偶联细胞穿膜肽TAT |
222 |
h |
2024-12-13 |
| 86639 |
Cl-C6-PEG4-NHCO-C3-NHS，氯-C6--四聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
195 |
kx |
2024-12-13 |
| 86640 |
dysprosium-DOTA-PAMAM |
166 |
h |
2024-12-13 |
| 86641 |
Cl-C6-PEG3-NHCO-C3-NHS，氯-C6--三聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
226 |
kx |
2024-12-13 |
| 86642 |
Y-DOTA-TOC,CAS：293295-66-6 |
172 |
h |
2024-12-13 |
| 86643 |
DOTA-MAL-Cys39-exendin-4 |
193 |
h |
2024-12-13 |
| 86644 |
DO3A叔丁酯,CAS: 122555-91-3 |
381 |
h |
2024-12-13 |
| 86645 |
1202761-21-4，Biotinyl-NH-PEG3-C3-amido-C3-COOH |
190 |
kx |
2024-12-13 |
| 86646 |
(m-PEG4)2-C-C3-Br |
181 |
kx |
2024-12-13 |
| 86647 |
1,1,4,4,7,7-六(1,1-二甲基乙基)10,10-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸酯 |
345 |
h |
2024-12-13 |
| 86648 |
二乙酰氧二辛基锡盐,CAS:17586-94-6 |
207 |
h |
2024-12-13 |
| 86649 |
二苯基环辛炔-聚乙二醇-大环配体 |
147 |
h |
2024-12-13 |
| 86650 |
Azide-PEG11-CH2CH2CH2-COOtBu，叠氮-十一聚乙二醇-C3-叔丁酯 |
193 |
kx |
2024-12-13 |
| 86651 |
(S)-4-(4-(3-((4-((2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL) |
207 |
h |
2024-12-13 |
| 86652 |
DOTA四乙酸酯,CAS: 825625-07-8 |
406 |
h |
2024-12-13 |
| 86653 |
Boc-NH-PEG7-C3-acid，氨基叔丁酯-七聚乙二醇-C3-酸 |
147 |
kx |
2024-12-13 |
| 86654 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
192 |
h |
2024-12-13 |
| 86655 |
2731015-03-3，Boc-NH-PEG1-C3-acid，氨基叔丁酯-一聚乙二醇-C3-酸 |
175 |
kx |
2024-12-13 |
| 86656 |
Azide-PEG6-CH2CH2CH2-COOtBu，叠氮-六聚乙二醇-C3-叔丁酯 |
181 |
kx |
2024-12-13 |
| 86657 |
APN-C3-PEG5-acid， APN-C3-五聚乙二醇-羧酸 |
161 |
kx |
2024-12-13 |
| 86658 |
Pomalidomide-C3-NH2 hydrochloride的主要结构与功能基团 |
181 |
kx |
2024-12-13 |
| 86659 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl)ester,(αR)- |
169 |
h |
2024-12-13 |
| 86660 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
174 |
h |
2024-12-13 |
| 86661 |
Azide-C3-Iodoacetamide的应用领域 |
169 |
kx |
2024-12-13 |
| 86662 |
CAS: 1161883-51-7，Propargyl-PEG5-CH2CO2-NHS |
213 |
WYQ |
2024-12-13 |
| 86663 |
CAS: 1429934-37-1，Propargyl-PEG5-CH2CO2H |
135 |
WYQ |
2024-12-13 |
| 86664 |
CAS：1610950-41-8,DOTA-甲基四嗪 |
142 |
h |
2024-12-13 |
| 86665 |
CAS: 1694731-93-5，Propargyl-PEG4-CH2CO2H |
118 |
WYQ |
2024-12-13 |
| 86666 |
CAS: 141282-35-1，Amino-PEG5-CH2CO2H（氨基-五聚乙二醇-乙酸） |
167 |
WYQ |
2024-12-13 |
| 86667 |
2768332-86-9，FmocNH-C2-NHCO-PC-NHCO-C4-COOH，N-芴甲氧羰基-C2-酰胺-PC-酰胺-C4-羧酸 |
128 |
kx |
2024-12-13 |
| 86668 |
CAS：1345034-50-5,DOTA-(COOt-Bu)3 |
141 |
h |
2024-12-13 |
| 86669 |
CAS: 195071-49-9，Amino-PEG4-CH2CO2H（氨基-四聚乙二醇-乙酸） |
161 |
WYQ |
2024-12-13 |
| 86670 |
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA(HCl salt) |
140 |
h |
2024-12-13 |
齐岳微信公众号
官方微信
库存查询